Shiow-Luan Tsay

Shiow-Luan Tsay

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2020 in Journal of Nursing Research
Verified
Journal Article
Open access
SCShu-Ching Chen
Shu-Ching Chen
YLYeur-Hur Lai
Yeur-Hur Lai
STShiow-Luan Tsay
Shiow-Luan Tsay

30 March 2013 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
HHHsiu-Chi Hung
Hsiu-Chi Hung
TCTsui-Wei Chien
Tsui-Wei Chien
STShiow-Luan Tsay
Shiow-Luan Tsay
HHHewi-Ming Hang
Hewi-Ming Hang
SLShu-Yuan Liang
Shu-Yuan Liang
Patient and Clinical Variables Account for Changes in Health-related Quality of Life and Symptom Burden as Treatment Outcomes in Colorectal Cancer: A Longitudinal Study HRQoL;pain;symptom;outcomes;colorectal cancer;GEE;Taiwan; Objective: The aim of the current study was to evaluate changes in treatment outcomes in terms of health-related quality of life (HRQoL) and symptom burden at zero, one, three, and six months after an initial diagnosis of colorectal cancer. The demographic and clinical characteristics that account for outcome changes in patients were investigated using a repeated measures framework. Methods and Materials: A cohort study was performed of 134 colorectal cancer patients followed from diagnosis to 6 months post-treatment in Central Taiwan. HRQoL and symptoms were assessed at diagnosis and one, three, and six months thereafter. The Functional Assessment of Cancer Therapy-Colon (FACT-C) questionnaire, VAS pain, and the Memorial Symptom Assessment Scale (MSAS) were used for data collection. A generalized estimating equation (GEE) was applied for statistical analysis. Results: The majority of the patients were male (55%) and married (91.5%). The mean age was 60.4 years (SD = 11.71). Most were diagnosed stage III and IV colorectal cancer (54.5%). All underwent surgery; some also received chemotherapy (CT) or concurrent chemoradiation therapy (CCRT). The results of the GEE showed that overall, the HRQoL, pain, and symptoms of the patients significantly improved over the treatment period. Patients with stage IV disease who had received surgery and CCRT showed the worst HRQoL. Females, patients with comorbidity, and stage IV patients had higher pain scores over time. Female and stage IV patients had more severe physical symptoms, whereas stage II and IV patients had worse psychological symptoms over time. Conclusion: The patients' HRQoL, pain, and symptoms significantly improved over the 6-month treatment period. Certain patient and clinical variables accounted for changes in treatment outcomes regarding HRQoL and symptom burden in colorectal cancer patients.

16 February 2022 in Journal of Nursing Management
Verified
Journal Article
Closed access
PDF file
LLLee‐Pi Lei
Lee‐Pi Lei
KLKuan‐Pin Lin
Kuan‐Pin Lin
SHSheng‐Shiung Huang
Sheng‐Shiung Huang
HTHeng-Hsin Tung
Heng-Hsin Tung
JTJung‐Mei Tsai
Jung‐Mei Tsai
STShiow-Luan Tsay
Shiow-Luan Tsay

1 December 2018 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
LTLi-Yun Tsai
Li-Yun Tsai
SLShu-Chen Lee
Shu-Chen Lee
KWKung-Liahng Wang
Kung-Liahng Wang
STShiow-Luan Tsay
Shiow-Luan Tsay
JTJung-Mei Tsai
Jung-Mei Tsai
The purpose of this study was to examine the correlations among fear of cancer recurrence (FCR), illness representation (IR), self-regulation (SR), and quality of life (QOL) in gynecologic cancer survivors. A cross-sectional study was conducted with 287 participants recruited from a medical center in northern Taiwan. Four questionnaires, the Assessment of Survivor Concerns (ASC), the Brief Illness Perception Questionnaire (BIPQ), the Self-Regulation Questionnaire (SRQ), and the European Organization for Research and Treatment of Cancer's Quality-of-Life Questionnaire-Core 30-item (EORTC QLQ-C30), were used to assess FCR, IR, SR, and QOL respectively. Data pertaining to socio-demographic characteristics and self-reported medical status was also collected from the participants. Stepwise regression analysis was performed to identify predictors of QOL. The results showed that FCR (r = -.21, P < .01) and IR (r = -.44, P < .01) was negatively correlated with global QOL subscale of the EORTC QLQ-C30. SR, IR, and health status in the self-reported medical status explained 39% of the variance in global QOL, with SR of the largest. Our findings provided valuable information to healthcare professionals about the ability of SR to affect QOL and negative impacts of FCR and IR on gynecologic cancer survivors.

1 February 2020 in Asian Nursing Research
Verified
Journal Article
Open access
SLShuyuan Liang
Shuyuan Liang
HLHui-Chun Liu
Hui-Chun Liu
YLYu-Ying Lu
Yu-Ying Lu
SWShu-Fang Vivienne Wu
Shu-Fang Vivienne Wu
CCChing-Hui Chien
Ching-Hui Chien
STShiow-Luan Tsay
Shiow-Luan Tsay
The purpose of this study was to assess the amount of variance in the coping strategies of patients with brain tumors that could be accounted for by resilience. This cross-sectional survey involved 95 patients who had experienced surgical, chemotherapy, or radiotherapy therapies for their brain tumors at least 1 month before data collection. The investigator collected data using the scales of the Ways of Coping Checklist-Revised and Resilience Scale. Data were analyzed using descriptive statistics, t tests, analysis of variance, Pearson product-moment correlation, and hierarchical multiple regression. The results revealed that resilience was significantly positively associated with patients' problem-focused coping (r = .65, p < .001) and total coping (r = .49, p < .001). In addition, resilience accounted for 27% (R2inc = .27, p < .001) and 16% (R2inc = .16, p < .001) of the distinct variances in predicting patients' problem-focused coping and total coping. The current results provide evidence to support the importance of resilience in shaping the coping strategies of relevant patients. As resilience shows a crucial element in patient coping with brain tumors, health team members should develop and employ appropriate strategies to improve the resilience of patients with brain tumors.

15 May 2023 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
JTJung-Mei Tsai
Jung-Mei Tsai
LTLi-Yun Tsai
Li-Yun Tsai
STShiow-Luan Tsay
Shiow-Luan Tsay
YCYi-Heng Chen
Yi-Heng Chen
Postpartum depression (PPD) is common and detrimental affecting both maternal health and child development. The purpose of this study was to determine the prevalence and factors of PPD screened immediately after delivery. A retrospective study design using secondary data analysis is applied. Four years of data, containing linkable maternal, neonate and PPD screen records between 2014 and 2018, was retrieved and combined from the electronic medical systems of MacKay Memorial Hospital in Taiwan. For each woman, the PPD screen record contained self-reported depressive symptoms assessed by the Edinburgh Postnatal Depression Scale (EPDS) within 48-72 h after delivery. A set of factors pertaining to maternal, pregnancy and obstetric, neonatal and breastfeeding were selected from the combined data set. In total, 10.2% (1244 of 12,198) of women reported with the symptoms of PPD (EPDS ≥10). Through logistic regression analysis, eight predictors of PPD were identified. Specifically, PPD was shown to be associated with educational level of high school or lower (odds ratio (OR) = 1.57, 95% confidence interval (CI) 1.27-1.93), marital status of unmarried (OR = 1.52, 95% CI 1.18-1.99), unemployed (OR = 1.26, 95% CI 1.11-1.42), Cesarean section (OR = 1.7, 95% CI 1.5-1.93), unplanned pregnancy (OR = 1.38, 95% CI = 1.22-1.57), gestational age at 24-36 weeks (OR = 1.3, 95% CI 1.08-1.56), non-intention of breastfeeding (OR = 1.7, 95% CI 1.18-2.45) and Apgar at 5 min < 7 (OR = 2.18, 95% CI 1.11-4.29). Low educational level, unmarried, unemployed, Caesarean section, unplanned pregnancy, preterm delivery, not breastfeeding and low Apgar at 5 min are predictors for postpartum women to develop PPD. These predictors are easily recognized in the clinical environment for patient guidance, support and referral as early as possible to ensure the health and well-being of the mothers and the neonates.